The short answer

New Zealand's public health system provides emergency and acute care that private insurance does not attempt to replicate — and for anything urgent, the public system is where you want to be. Private health insurance buys you three things it does not: speed on elective treatment, choice of specialist and timing, and access to cancer drugs Pharmac does not fund.

Last reviewed 2026-07-30

Where the public system is better, full stop

  • Emergencies and acute care. Heart attack, major trauma, stroke — you go public, it is free, and it is good. No private policy improves on this.
  • Complex and intensive care. ICU, major multi-disciplinary work, rare conditions.
  • Anything urgent. Clinical priority means genuinely urgent cases are treated quickly.
  • Cost. It is already paid for.

Where private cover earns its premium

  • Elective surgery. Hips, knees, hernias, gallbladders, ENT, gynaecology. Painful, life-limiting, and not clinically urgent — which is exactly the category that waits.
  • Diagnostics. Getting the scan in a fortnight rather than months, which shortens the whole uncertainty.
  • Non-Pharmac cancer drugs. The one most people underestimate. Pharmac funds a narrower list of modern cancer medicines than several comparable countries, and better health policies carry a benefit — often $300,000–$500,000 — specifically for drugs outside it.
  • Choosing your surgeon and your date. Which matters more than it sounds if you are self-employed and scheduling around income.
Free & excellentEmergency, acute and complex care — public
The queueElective surgery, where private buys time
Non-funded drugsThe benefit most often underestimated
Bare hills reflected in a perfectly still South Island lake

Private cover does not buy better medicine. It buys a different calendar.

Deciding honestly

This is the one cover on this site where a financially literate person can reasonably say no. The questions that actually settle it:

  1. What does waiting cost you? A salaried employee with sick leave and an office job pays little for a six-month wait. A self-employed builder pays enormously.
  2. Could you self-fund a $60,000 surgery? If yes, you are insuring a risk you can absorb.
  3. Could you self-fund $200,000 of non-funded cancer drugs? Almost nobody can, and this is the part of the decision most often made on a wrong assumption about what Pharmac covers.
  4. What is your health history now? Because it only gets harder to insure from here. See pre-existing conditions.

The middle option people forget

You do not have to choose between full cover and nothing. A hospital-and-surgical plan with a high excess and no extras module is often a fraction of the price of a comprehensive plan and keeps the two things that matter most — surgical cover and the non-Pharmac drug benefit. For a lot of households that is the honest sweet spot, and it is rarely what gets quoted first. More on the excess lever →

Common follow-up questions

If I have health insurance, can I still use the public system?

Yes. Having private cover does not remove your entitlement to public healthcare. Many people use public for emergencies and private for elective work — that is the normal pattern, not a loophole.

Does health insurance make me a queue-jumper?

You are not moving ahead of anyone in the public queue — you are leaving it, which if anything shortens it by one. That is the structural argument. Whether a two-tier system is good policy is a fair debate, but it is a different question from whether cover benefits you personally.

What about GP visits and prescriptions?

Those sit in optional everyday/extras modules that, for most households, return roughly what they cost. The high-value part of health insurance is surgical and non-Pharmac drug cover. If budget is tight, keep those and drop the extras.

Keep reading

This page is general information about how insurance works in New Zealand. It is not regulated financial advice and it does not take your situation into account. For advice about your own cover, talk to a licensed financial adviser.